Vilazodone (United States trade name Viibryd VEYE-brid) is a serotonergic antidepressant developed by Clinical Data for the treatment of major depressive disorder. The chemical compound was originally developed by Merck KGaA (Germany). Vilazodone was approved by the FDA for use in the United States to treat major depressive disorder in 2011.

CAS：163521-12-8
中文别名：维拉唑酮;
英文别名：5-(4-(4-(5-Cyano-1H-indol-3-yl)butyl)piperazin-1-yl)benzofuran-2-carboxamide;5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]piperazin-1-yl]-1-benzofuran-2-carboxamide;
分子式：C26H28ClN5O2
分子量：477.986
精确质量：477.193
Psa：102.29
Logp：5.53478

MDL号：MFCD09838919

外观与性状：淡黄色固体
密度：1.34 g/cm3
沸点：745.1ºC at 760 mmHg
熔点：203-205ºC